CLINICAL TRIALS PROFILE FOR NORDITROPIN
✉ Email this page to a colleague
All Clinical Trials for Norditropin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00102817 ↗ | Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children | Completed | Novo Nordisk A/S | Phase 3 | 2003-05-01 | This trial is conducted in the United States of America (USA). This is a 12 month study to determine if Norditropin is safe and effective in children with IGF deficiency. |
NCT00184652 ↗ | Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease | Completed | Novo Nordisk A/S | Phase 2 | 2003-04-01 | This trial is conducted in Asia, Europe, and Middle East. Adult patients with chronic kidney disease are treated with growth hormone to assess effect on nutritional status. |
NCT00184678 ↗ | Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency | Completed | Novo Nordisk A/S | Phase 3 | 2002-02-01 | This trial is conducted in Europe. Growth Hormone in young adults with growth hormone deficiency in childhood. This trial compares a treated group of patients with an untreated group of patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Norditropin
Condition Name
Clinical Trial Locations for Norditropin
Trials by Country
Clinical Trial Progress for Norditropin
Clinical Trial Phase
Clinical Trial Sponsors for Norditropin
Sponsor Name